GelMEDIX
Technology to revolutionize ocular cell therapies
Cambridge, United States
12 employees
Debt Financing
Total: $1.89M
Biotechnology, Health Care +1
General Information
Cambridge, United States
BounceWatch is an independent company data service, not affiliated with GelMEDIX. To contact GelMEDIX, visit gelmedix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does GelMEDIX compare?
A PDF of GelMEDIX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting GelMEDIX soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About GelMEDIX
Business keywords: ocular cell therapy, regenerative therapy, hydrogel platform, vision restoration, macular degeneration, Dry AMD, GA, tissue regeneration, bioadhesion, tunable mechanics, therapeutic loading, cell therapy, gene therapy, small molecule therapy
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $1.89M | - |
|
11 Mar 2024 |
| Seed Round | Undisclosed | 2 |
|
10 Mar 2022 |
| Convertible Note | Undisclosed | 2 |
|
04 Jun 2020 |
GelMEDIX Alternatives & Competitors
View All Alternatives
Transforming Vision, Transforming Lives
Bringing vision back to life.
Optogenetic Gene Therapy Company
FAQ About GelMEDIX
Source: BounceWatch company record for GelMEDIX, https://bouncewatch.com/company/gelmedix, updated 14 November 2024. When citing, please name BounceWatch and link this page.
